Premium
Hydroxychloroquine retinal toxicity in two patients with dermatological conditions
Author(s) -
Kowalski Tanya,
Baker Christopher,
Mack Heather G
Publication year - 2018
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12827
Subject(s) - hydroxychloroquine , medicine , dosing , toxicity , dermatology , retinal , retinopathy , intensive care medicine , ophthalmology , covid-19 , pharmacology , pathology , disease , infectious disease (medical specialty) , diabetes mellitus , endocrinology
Two patients with dermatological conditions developed retinal toxicity after treatment with hydroxychloroquine that exceeded dosing recommendations. There is no treatment for hydroxychloroquine retinal toxicity and associated visual loss, so appropriate monitoring is imperative. All members of a patient's multidisciplinary team should be aware of the ocular risks of hydroxychloroquine, the importance of dosing within recommended guidelines and appropriate monitoring in reducing the risk of visual loss.